Overview

The Efficacy of Glucagon Like Peptide (GLP) - 1(7-36) Amide for Glycemic Control in Critically Ill Patients

Status:
Terminated
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
The goal of this present proposal is to examine the efficacy of GLP-1 administered to control blood glucose in critically ill patients.
Phase:
Phase 2
Details
Lead Sponsor:
Johns Hopkins University
Collaborator:
Society of Critical Care Medicine
Treatments:
Glucagon
Glucagon-Like Peptide 1